Press Releases

EIN Presswire

MIAMI, FL, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- Shomari Scott, Chief Business Officer of Health City Cayman Islands and a seasoned tourism and brand strategist, was honored with a 2025 Caribbean Media Exchange (CMEx) Leadership...

GlobeNewswire, Inc.

NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- As families brace for holiday travel chaos, the Cayman Islands is offering a welcome antidote: a vaCay that restores instead of exhausts.

EIN Presswire

GRAND CAYMAN, CAYMAN ISLANDS, November 19, 2025 /⁨EINPresswire.com⁩/ -- Health City Cayman Islands has reached a significant milestone, with its Sleep Lab having treated its 2,000th patient since opening in 2015. The achievement underscores the...

EIN Presswire

CAYMAN ISLANDS, November 1, 2025 /⁨EINPresswire.com⁩/ -- Health City Cayman Islands, the largest private sector medical entity in the Cayman Islands and one of the largest in the Caribbean, has announced the acquisition of Practice Plus Group by...

EIN Presswire

CAYMAN ISLANDS, September 28, 2025 /⁨EINPresswire.com⁩/ -- Health City Cayman Islands has rebranded its flagship youth program, Healthcare Explorers, as Health City Explorers to strengthen the program’s connection to the internationally recognized...

GlobeNewswire, Inc.

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies, positive German regulatory feedback, and strong...

GlobeNewswire, Inc.

Hong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- Phoenix Asia Holdings Limited (the “Company” or “Phoenix Asia”) (NASDAQ: PHOE), a Hong Kong-based company mainly engaged in substructure works, announces a significant update in its business development....

GlobeNewswire, Inc.

Positive feedback reinforces Silexion’s trajectory toward its planned Phase 2/3 trial initiation in Q2 2026 Company plans to complete regulatory submissions to the Israeli Ministry of Health by the end of Q4 2025 and in Germany during Q1 2026...

GlobeNewswire, Inc.

Successful completion of two-species toxicology studies confirms no systemic organ toxicity, advancing the Company towards its planned regulatory submissions to Israel and Germany Company remains on track to initiate Phase 2/3 clinical trial in...

GlobeNewswire, Inc.

FOSTER CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”) (Nasdaq: APLM) announced today entering into a settlement agreement (the “Settlement Agreement” or the “Agreement”) with TWVC Goldlink Partners...

EIN Presswire

CAYMAN ISLANDS, July 11, 2025 /⁨EINPresswire.com⁩/ -- In a landmark development for the Cayman Islands’ medical community, the Cayman Islands Society of Anaesthesiologists (CISA) was officially launched during the first-ever Cayman Islands Society...

GlobeNewswire, Inc.

ZURICH, SWITZERLAND, and MARTINSRIED/MUNICH, GERMANY – September 30, 2025 -- VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), and...

EIN Presswire

GRAND CAYMAN, CAYMAN ISLANDS, September 16, 2025 /⁨EINPresswire.com⁩/ -- Just months ago, Turks and Caicos Islands’ beloved community figure, Martha Parker, lay motionless in a hospital bed, paralyzed from the neck down and fighting for her life....

EIN Presswire

CAYMAN ISLANDS, August 28, 2025 /⁨EINPresswire.com⁩/ -- Turks and Caicos Islands Minister of Health and Human Services Kyle Knowles has described Health City Cayman Islands as offering “world-class facilities” comparable to those in the United...

GlobeNewswire, Inc.

New York, NY and Singapore, May 01, 2026 (GLOBE NEWSWIRE) -- Blueport Acquisition Ltd (Nasdaq: BPAC) (“Blueport”), a publicly traded special purpose acquisition company, and SingAuto Inc (“SingAuto”), a global innovator providing green cold-chain...

GlobeNewswire, Inc.

Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 Following Q4 2025 and Q1 2026 Regulatory...

GlobeNewswire, Inc.

FDA confirmed at a July 2025 Type B meeting and in the subsequent meeting minutes that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with type 2 diabetes and advanced CKD; FDA also confirmed...

GlobeNewswire, Inc.

WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public...

GlobeNewswire, Inc.

WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the...

GlobeNewswire, Inc.

Hong Kong, July 17, 2025 (GLOBE NEWSWIRE) -- Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), today announced that it has entered into a legally-binding memorandum of understanding (the “MOU”) with Jilin Xiuzheng...